|
Identifying molecular drivers of tumor heterogeneity in pancreatic cancer
|
1F31CA224792-01A1
|
$36,672
|
|
ADAMS, CHRISTINA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
|
1R01CA236615-01
|
$392,764
|
|
ADUSUMILLI, PRASAD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-04S1
|
$145,357
|
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Targeting galectin-3 to overcome drug resistance in metastatic prostate cancer therapy
|
1R43CA228813-01A1
|
$300,000
|
|
AHMED, HAFIZ
|
GLYCOMANTRA, INC.
|
|
Chemically produced neural progenitors loaded with ferumoxide-protamine sulfate complex for visualization of gliomas
|
1R43CA228726-01A1
|
$300,000
|
|
ALEXANIAN, ARSHAK
|
CELL REPROGRAMMING AND THERAPEUTICS, LLC
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-49S1
|
$142,498
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-04
|
$701,778
|
$56,142
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Resource stratified phased implementation frameworks to improve breast healthcare
|
1R13CA224776-01A1
|
$50,000
|
|
ANDERSON, BENJAMIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
|
1U01CA232382-01
|
$688,043
|
|
ANDERSON, ALEXANDER
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Development of an MRI-compatible, High-Frequency Irreversible Electroporation (H-FIRE) System for Non-thermal Ablation of Inoperable Brain Tumors
|
1R43CA233158-01
|
$244,498
|
|
ARENA, CHRISTOPHER
|
VOLTMED, INC.
|
|
Cancer Genetics of Short Telomere Syndromes
|
1R01CA225027-01A1
|
$530,521
|
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Predicting the Presence of Clinically Significant Prostate Cancer using Multiparametric MRI and MR-US Fusion Biopsy
|
1R21CA220352-01A1
|
$195,568
|
|
ARNOLD, COREY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Role of HER2 mutations in breast cancer progression and response to targeted therapies
|
1R01CA224899-01A1
|
$382,641
|
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
Cone Beam Tomosynthesis Fluoroscopy for Image Guided Interventions
|
3R43CA228158-01A1S1
|
$50,000
|
|
ATRIA, CRISTIAN
|
NVIEW MEDICAL, INC.
|
|
Contribution of development and age to breast cancer etiology
|
3R01CA190980-04S1
|
$58,563
|
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Targeting the Major Histocompatibility Class I-LILRB1 signaling axis for cancer immunotherapy by macrophages
|
1F30CA232472-01
|
$43,039
|
|
BARKAL, AMIRA
|
STANFORD UNIVERSITY
|
|
Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate Cancer
|
1R01CA226211-01A1
|
$485,064
|
|
BASARIA, SHEHZAD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S4
|
$114,251
|
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA022453-36S1
|
$131,250
|
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
3R01CA197359-04S1
|
$68,577
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Genomic Evaluation of the Female Survival Advantages in Melanoma
|
3P01CA206980-02S2
|
$75,897
|
|
BERWICK, MARIANNE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Histone deacetylases 1,2 and DNA repair
|
3R01CA188520-04S1
|
$20,472
|
|
BHASKARA, SRIVIDYA
|
UNIVERSITY OF UTAH
|
|
Mitigating Long-term Treatment-related Morbidity in Childhood Cancer Survivors
|
1R35CA220502-01A1
|
$867,671
|
|
BHATIA, SMITA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
3P30CA013148-46S1
|
$52,084
|
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Integration of 3D primary tumor drug-profiling with patient-specific drug gene networks for recommending targeted cancer therapies (2 of 2).
|
3R21CA220398-02S1
|
$77,750
|
|
BOCA, SIMINA
|
GEORGETOWN UNIVERSITY
|
|
Development of a Tumor-Specific PROTAC
|
1F31CA232477-01
|
$44,524
|
|
BOND, MICHAEL
|
YALE UNIVERSITY
|
|
Radiogenomic tools for prediction of breast cancer neo-adjuvant chemotherapy response from pre-treatment MRI
|
1F31CA221383-01A1
|
$42,074
|
|
BRAMAN, NATHANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
The power of extracellular vesicles in glioblastoma
|
1R35CA232103-01
|
$935,071
|
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Elucidating the Role of Long Interspersed Element-1 (LINE-1) Expression and Retrotransposition in Prostate Cancer Progression
|
1F31CA225053-01A1
|
$44,524
|
|
BRIGGS, ERICA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Role of Oncometabolite L-2 Hydroxyglutarate in Reprogramming Renal Cell Carcinoma Metabolism
|
1F30CA232397-01
|
$37,434
|
|
BRINKLEY, GARRETT
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Optimization and Evaluation of Anatomical Models of Liver Radiation Response
|
1R01CA221971-01A1
|
$362,432
|
|
BROCK, KRISTY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
High speed automated intraoperative microscopy of the prostate circumference to ensure tumor-free margins in radical prostatectomy
|
1R01CA222831-01A1
|
$456,329
|
|
BROWN, JONATHAN
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Using Microfluidic Single Cell Culture to Characterize Cancer Cell Asymmetric Division
|
7R01CA203810-02
|
$412,307
|
|
BUCKANOVICH, RONALD
|
MAGEE-WOMEN'S RES INST AND FOUNDATION
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Sixth International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma
|
1R13CA232383-01
|
$5,000
|
|
CAIRO, MITCHELL
|
NEW YORK MEDICAL COLLEGE
|
|
The role of Sin3B in coordinating cell cycle exit and differentiation in hematopoiesis
|
1F31CA232659-01
|
$44,524
|
|
CALDERON, ALEXANDER
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Cancer Center Support Grant
|
3P30CA016058-42S1
|
$59,783
|
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
miR-155 targeted therapeutics for precision medicine in lung cancer
|
1R01CA222007-01A1
|
$536,674
|
|
CALIN, GEORGE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using mobile technology to understand the impact of socioeconomic and neighborhood factors on smoking cessation
|
1F32CA232796-01
|
$58,282
|
|
CAMBRON, CHRISTOPHER
|
UNIVERSITY OF UTAH
|
|
3D biomimetic image-based stromal models of pancreatic cancer for drug screening
|
1R21CA224280-01A1
|
$213,829
|
|
CAMPAGNOLA, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
FANCJ dependent pathways in replication stress
|
1R01CA225018-01A1
|
$404,864
|
|
CANTOR, SHARON
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Handheld two-photon microscopy for intra-operative cancer margin assessment
|
1F32CA232386-01
|
$58,654
|
|
CARRASCO-ZEVALLOS, OSCAR
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
2018 Cell Death Gordon Research Conference and Gordon Research Seminar
|
1R13CA232392-01
|
$4,000
|
|
CHAN, FRANCIS
|
GORDON RESEARCH CONFERENCES
|
|
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
|
1R35CA232097-01
|
$1,040,850
|
|
CHAN, TIMOTHY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
7R01CA182528-06
|
$392,355
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting TET1 signaling to treat acute myeloid leukemia
|
7R01CA211614-02
|
$475,560
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
Total relevant funding to Penis for this search: $651,482
|